Edgewise Therapeutics, Inc. (EWTX)
NASDAQ: EWTX · Real-Time Price · USD
14.87
+0.08 (0.54%)
At close: May 20, 2025, 4:00 PM
14.91
+0.04 (0.27%)
After-hours: May 20, 2025, 4:48 PM EDT
Edgewise Therapeutics Market Cap
Edgewise Therapeutics has a market cap or net worth of $1.57 billion as of May 20, 2025. Its market cap has decreased by -13.04% in one year.
Market Cap
1.57B
Enterprise Value
1.17B
1-Year Change
-13.04%
Ranking
Category
Stock Price
$14.87
Market Cap Chart
Since the IPO on March 26, 2021, Edgewise Therapeutics's market cap has increased from $761.07M to $1.57B, an increase of 105.89%. That is a compound annual growth rate of 19.00%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 19, 2025 | 1.56B | -38.46% |
| Dec 31, 2024 | 2.53B | 264.15% |
| Dec 29, 2023 | 694.27M | 22.85% |
| Dec 30, 2022 | 565.13M | -24.97% |
| Dec 31, 2021 | 753.24M | -1.03% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 673.19B |
| Johnson & Johnson | 369.45B |
| AbbVie | 326.06B |
| Novo Nordisk | 293.82B |
| UnitedHealth Group | 290.90B |
| Abbott Laboratories | 235.19B |
| Novartis AG | 215.48B |
| AstraZeneca | 214.95B |